Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Rathat, C."'
Publikováno v:
British Journal of Anaesthesia. 66:324-326
The purpose of this study was to define the optimum dose of lignocaine required to reduce pain on injection of propofol. We conducted a prospective, randomized, double-blind trial on 310 patients undergoing anaesthesia. Patients were allocated to fou
Publikováno v:
Europe PubMed Central
Publikováno v:
Europe PubMed Central
A professional mountain guide experienced an attack of vertigo at high altitude (4,000 m). Clinical data and the results of functional tests, were consistent with an attack of Meniere's disease. The physiopathological changes noted at high altitudes,
Publikováno v:
European Journal of Applied Physiology & Occupational Physiology; 1988, Vol. 57 Issue 6, p740-745, 6p
Autor:
Richalet, J.-P., Mehdioui, H., Rathat, C., Vignon, P., Keromes, A., Herry, J.-P., Sabatier, C., Tanche, M., Lhoste, F.
Publikováno v:
International Journal of Sports Medicine; 1988, Vol. 9 Issue 2, p157-162, 6p
Publikováno v:
Journal of Applied Physiology; 1988, Vol. 65 Issue 5, p1957-1961, 5p
Autor:
Richalet, J. P., Merlet, P., Bourguignon, M., Le-Trong, J. L., Kéromès, A., Rathat, C., Jouve, B., Hot, M. Ah., Castaigne, A., Syrota, A.
Publikováno v:
Journal of Nuclear Medicine; Jan1990, Vol. 31 Issue 1, p34-37, 4p, 1 Color Photograph, 2 Charts, 1 Graph
Publikováno v:
Europe PubMed Central
Exercising in high altitude is impeded during the first days of exposure to altitude hypoxia by the symptoms of Acute Mountain Sickness (AMS). Susceptibility to AMS is independent of endurance training and determined by the sensitivity of carotid che
Publikováno v:
International Journal of Sports Medicine; Supplement 1992, Vol. 13, pS76-S78, 3p
Autor:
Jean-Paul Richalet, Merlet P, Bourguignon M, Jl, Le-Trong, Kéromès A, Rathat C, Jouve B, Ma, Hot, Castaigne A, Syrota A
Publikováno v:
Europe PubMed Central
High altitude hypoxia induces a decrease in the cardiac chronotropic function at maximal exercise or in response to isoproterenol infusion, suggesting an alteration in the cardiac sympathetic activation. Iodine-123 metaiodobenzylguanidine [( 123I]MIB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::21d578a1047f271976563d754b685eff
http://europepmc.org/abstract/med/2295937
http://europepmc.org/abstract/med/2295937